These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31732566)

  • 81. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Neural Basis of Apathy in Patients with Amnestic Mild Cognitive Impairment.
    Kazui H; Takahashi R; Yamamoto Y; Yoshiyama K; Kanemoto H; Suzuki Y; Sato S; Azuma S; Suehiro T; Shimosegawa E; Ishii K; Tanaka T
    J Alzheimers Dis; 2017; 55(4):1403-1416. PubMed ID: 27858707
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease.
    Martin WR; Wieler M; Stoessl AJ; Schulzer M
    Ann Neurol; 2008 Mar; 63(3):388-94. PubMed ID: 18240153
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia.
    Jokinen P; Scheinin N; Aalto S; Någren K; Savisto N; Parkkola R; Rokka J; Haaparanta M; Röyttä M; Rinne JO
    Parkinsonism Relat Disord; 2010 Dec; 16(10):666-70. PubMed ID: 20870446
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cholinergic nucleus 4 grey matter density is associated with apathy in Parkinson's disease.
    Sperling SA; Druzgal J; Blair JC; Flanigan JL; Stohlman SL; Barrett MJ
    Clin Neuropsychol; 2023 Apr; 37(3):676-694. PubMed ID: 35443870
    [No Abstract]   [Full Text] [Related]  

  • 86. Gender differences in cholinergic and dopaminergic deficits in Parkinson disease.
    Kotagal V; Albin RL; Müller ML; Koeppe RA; Frey KA; Bohnen NI
    J Neural Transm (Vienna); 2013 Oct; 120(10):1421-4. PubMed ID: 23532360
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cognitive Reserve in Parkinson's Disease without Dementia: β-Amyloid and Metabolic Assessment.
    Fernández-Rodríguez B; Rodríguez-Rojas R; Guida P; Angulo-Díaz-Parreño S; Trompeta C; Mata-Marín D; Obeso I; Vela L; Plaza de Las Heras I; Obeso JA; Gasca-Salas C
    Mov Disord Clin Pract; 2024 Mar; 11(3):282-288. PubMed ID: 38169114
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Color discrimination errors associate with axial motor impairments in Parkinson's disease.
    Bohnen NI; Haugen J; Ridder A; Kotagal V; Albin RL; Frey KA; Müller MLTM
    Mov Disord Clin Pract; 2017; 4(6):864-869. PubMed ID: 29226177
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Progression of regional cortical cholinergic denervation in Parkinson's disease.
    Bohnen NI; Roytman S; Kanel P; Müller MLTM; Scott PJH; Frey KA; Albin RL; Koeppe RA
    Brain Commun; 2022; 4(6):fcac320. PubMed ID: 36569603
    [TBL] [Abstract][Full Text] [Related]  

  • 90. GABA
    Bohnen NI; Barr J; Vangel R; Roytman S; Paalanen R; Frey KA; Scott PJH; Kanel P
    Brain Sci; 2023 Dec; 13(12):. PubMed ID: 38137159
    [TBL] [Abstract][Full Text] [Related]  

  • 91. An exploration of apathy and impulsivity in Parkinson disease.
    Ahearn DJ; McDonald K; Barraclough M; Leroi I
    Curr Gerontol Geriatr Res; 2012; 2012():390701. PubMed ID: 22829814
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Apathy and impulsiveness in Parkinson disease: Two faces of the same coin?
    Palmeri R; Corallo F; Bonanno L; Currò S; Merlino P; Di Lorenzo G; Bramanti P; Marino S; Lo Buono V
    Medicine (Baltimore); 2022 Jul; 101(26):e29766. PubMed ID: 35776985
    [TBL] [Abstract][Full Text] [Related]  

  • 93. "Pseudo-syndromes" associated with Parkinson disease, dementia, apathy, anxiety, and depression.
    Weiss HD; Pontone GM
    Neurol Clin Pract; 2019 Aug; 9(4):354-359. PubMed ID: 31583191
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Learning the value of experience.
    Le Heron C; Chong TTJ
    Brain; 2024 Apr; 147(4):1127-1129. PubMed ID: 38530634
    [No Abstract]   [Full Text] [Related]  

  • 95. Retraction Note: The Interplay of Tau Protein and β-Amyloid: While Tauopathy Spreads More Profoundly Than Amyloidopathy, Both Processes Are Almost Equally Pathogenic.
    Pourhamzeh M; Joghataei MT; Mehrabi S; Ahadi R; Hojjati SMM; Fazli N; Nabavi SM; Pakdaman H; Shahpasand K
    Cell Mol Neurobiol; 2024 Mar; 44(1):29. PubMed ID: 38512519
    [No Abstract]   [Full Text] [Related]  

  • 96. Proteinopathy and longitudinal changes in functional connectivity networks in Parkinson disease.
    Campbell MC; Jackson JJ; Koller JM; Snyder AZ; Kotzbauer PT; Perlmutter JS
    Neurology; 2020 Feb; 94(7):e718-e728. PubMed ID: 31852813
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Abnormal Spontaneous Neural Activity in Parkinson's Disease With "pure" Apathy.
    Sun HH; Hu JB; Chen J; Wang XY; Wang XL; Pan PL; Liu CF
    Front Neurosci; 2020; 14():830. PubMed ID: 32848582
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The Impact of Amyloid-Beta Positivity with 18F-Florbetaben PET on Neuropsychological Aspects in Parkinson's Disease Dementia.
    Na S; Jeong H; Park JS; Chung YA; Song IU
    Metabolites; 2020 Sep; 10(10):. PubMed ID: 32977481
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Distinct neural circuits are associated with subclinical neuropsychiatric symptoms in Parkinson's disease.
    Tinaz S; Kamel S; Aravala SS; Sezgin M; Elfil M; Sinha R
    J Neurol Sci; 2021 Apr; 423():117365. PubMed ID: 33636663
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Recent progress in the applications of presynaptic dopaminergic positron emission tomography imaging in parkinsonism.
    Yang Y; Li X; Lu J; Ge J; Chen M; Yao R; Tian M; Wang J; Liu F; Zuo C
    Neural Regen Res; 2025 Jan; 20(1):93-106. PubMed ID: 38767479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.